Astera Labs (NASDAQ:ALAB) COO Sells 90,459 Shares

Astera Labs, Inc. (NASDAQ:ALAB) COO Sanjay Gajendra sold 90,459 shares of the firm’s stock in a transaction on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief operating officer directly owned 1,599,750 shares of the company’s stock, valued at approximately $231,467,827.50. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Sanjay Gajendra also recently made the following trade(s):

• On Monday, November 17th, Sanjay Gajendra sold 90,459 shares of Astera Labs stock. The stock was sold at an average price of $144.69, for a total transaction of $13,088,512.71.

Astera Labs Trading Up 1.8%

Shares of ALAB traded up $2.49 during trading hours on Wednesday, reaching $142.01. The company had a trading volume of 4,125,472 shares, compared to its average volume of 5,263,438. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The firm has a 50 day simple moving average of $190.50 and a 200-day simple moving average of $145.33. The company has a market capitalization of $23.99 billion, a price-to-earnings ratio of 127.94, a PEG ratio of 2.64 and a beta of 1.37.

Astera Labs (NASDAQ:ALAB) last issued its earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million during the quarter, compared to analysts’ expectations of $206.42 million. During the same period last year, the company posted $0.23 earnings per share. The firm’s quarterly revenue was up 103.9% compared to the same quarter last year. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Sell-side analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Fred Alger Management LLC boosted its stake in shares of Astera Labs by 13.0% during the 1st quarter. Fred Alger Management LLC now owns 1,560,033 shares of the company’s stock worth $93,087,000 after purchasing an additional 179,638 shares during the last quarter. Hoey Investments Inc. boosted its position in Astera Labs by 22.4% during the second quarter. Hoey Investments Inc. now owns 6,121 shares of the company’s stock worth $553,000 after acquiring an additional 1,121 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its position in Astera Labs by 21.6% during the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 14,781 shares of the company’s stock worth $1,336,000 after acquiring an additional 2,624 shares during the last quarter. Wealth Effects LLC purchased a new stake in Astera Labs in the 2nd quarter worth approximately $242,000. Finally, Maryland State Retirement & Pension System raised its holdings in Astera Labs by 37.7% in the 2nd quarter. Maryland State Retirement & Pension System now owns 6,960 shares of the company’s stock valued at $629,000 after acquiring an additional 1,906 shares during the last quarter. Hedge funds and other institutional investors own 60.47% of the company’s stock.

Analyst Ratings Changes

A number of research firms have commented on ALAB. Cowen reiterated a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. TD Cowen cut their price target on Astera Labs from $225.00 to $170.00 and set a “hold” rating for the company in a research note on Wednesday, November 5th. Morgan Stanley boosted their price objective on shares of Astera Labs from $200.00 to $210.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 5th. Roth Capital increased their price objective on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research note on Wednesday, November 5th. Finally, Jefferies Financial Group lifted their target price on shares of Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research report on Tuesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $184.82.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.